LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹295 Cr | ₹262 Cr | ₹233 Cr | ₹182 Cr | ₹139 Cr |
What is the latest Net Current Assets ratio of LINCOLN PHARMACEUTICALS ?
Year | Net Current Assets |
---|---|
Mar2023 | ₹295 Cr |
Mar2022 | ₹262 Cr |
Mar2021 | ₹233 Cr |
Mar2020 | ₹182 Cr |
Mar2019 | ₹139 Cr |
How is Net Current Assets of LINCOLN PHARMACEUTICALS Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2023 | ₹295 Cr | 12.41 | |
Mar2022 | ₹262 Cr | 12.65 | |
Mar2021 | ₹233 Cr | 27.68 | |
Mar2020 | ₹182 Cr | 31.51 | |
Mar2019 | ₹139 Cr | - |
Compare Net Current Assets of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,194.2 Cr | -0.1% | -0.3% | 52% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | -0.1% |
-0.3% |
52% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses